Viewing nowBeasin tablet 250 milligrams (Ciprofloxacin Hydrochloride)
Ciprofloxacin Hydrochloride 291mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

MFDS item code 200807647 · Notified 2008.07.10 · Insurance code 694000300
Treatment of genitourinary, respiratory/ear, nose, and throat, and other infections (gastrointestinal, skin, etc.)
This medication is used to treat infections caused by various bacteria, including Escherichia coli, Shigella, and Salmonella. It is effective for treating respiratory infections except for acute bronchitis and community-acquired pneumonia. Additionally, it is used for a range of infections including ear, nose, throat infections, bacterial prostatitis, urinary tract infections, and gonococcal cervicitis. It is applicable for treating a wide range of infections such as gastrointestinal and bile duct infections, skin, soft tissue, bones, and joint infections. However, as a fluoroquinolone, there is a risk of severe adverse reactions, and it should only be used for certain conditions such as acute bacterial sinusitis when no alternative treatment is available. Overall, it is effectively used to treat various bacterial infections.
(Tablets) ○ Adults: Administer ciprofloxacin 250 ~ 500 mg orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg twice daily. For acute infections, treatment is usually given for 5 ~ 10 days and continued for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance may be calculated using the following formulas: Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose may be increased to 750 mg per dose even in patients with severe renal impairment, but the patient's condition should be monitored carefully after administration. Adjust the dose appropriately according to symptoms.
This medication may cause serious adverse effects such as tendinitis, tendon rupture, peripheral neuropathy, and central nervous system reactions. Especially in patients with myasthenia gravis, symptoms may worsen, so it is advisable not to use this medication. This drug is only to be used in specific bacterial infections and should only be administered when no alternative treatment exists. Caution is required for elderly patients, those with impaired kidney function, and patients with a history of seizures. It should not be used by women who are pregnant or potentially pregnant, nursing mothers, individuals under 18 years of age, or patients with epilepsy. This medication interacts with many other drugs, so it is important to consult a healthcare expert before co-administration. Co-administration with certain drugs may increase the risk of adverse effects. Photosensitivity reactions may occur during treatment, so avoid strong sunlight or artificial UV exposure. If symptoms of pain, inflammation, tendon rupture, or neuropathy (such as numbness, tingling, etc.) occur, discontinue use immediately and consult a healthcare professional. It may affect mental health, so if symptoms of depression, hallucinations, or suicidal thoughts occur, stop taking the medication immediately. Diabetic patients requiring blood sugar control should closely monitor changes in blood sugar levels, and treatment should be sought immediately if hypoglycemic symptoms occur. In cases of overdose, deterioration of kidney function may occur, necessitating prompt treatment in emergencies. The safety of this drug has not been established for children and adolescents in growth, and it is not administered to them. Store in a container that is tightly closed to prevent air and moisture from entering, and keep at room temperature between 1°C and 30°C to maintain the drug's efficacy.
Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombotic venous inflammation, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythropenia, hemoglobin decrease, hematocrit decrease, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylactic reaction, anaphylactic-like shock, serum sickness-like reaction, decreased appetite, reduced food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory disturbances, sensory loss, loss of taste, tremor, convulsions, dizziness, mental confusion, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, hypersensitivity, increased intracranial pressure, dysmetria, multifocal neuropathy, visual disturbances, chromatopsia, diplopia, tinnitus, hearing loss, transient deafness, hearing impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, shortness of breath, laryngeal edema, nausea, diarrhea, anorexia, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal bloating, dyspepsia, colitis with bloody stools, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, drug-induced hypersensitivity syndrome, toxic epidermal necrolysis, fixed drug eruptions, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tension and cramps, joint swelling, muscle weakness, partial or complete tendon rupture, renal impairment, increased BUN, increased serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undiagnosed pain, discomfort, fever, asthenia, edema, sweating, gait disturbances, maculopapular rash, purpuric rash, aortic aneurysm, aortic dissection, mitral valve regurgitation, mitral valve insufficiency, shock, hypotension, chest tightness, muscular weakness, rhabdomyolysis, cough, interstitial pneumonia, visual impairment
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to prevent air and moisture from entering, and should be kept at room temperature between 1°C and 30°C. This storage condition will help maintain the medication's effectiveness.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCiprofloxacin Hydrochloride 291mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Ciprofloxacin Hydrochloride 291.5mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Ciprofloxacin Hydrochloride
Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 582mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Korea United Pharm, Inc.
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.